Avni named Beta-O2 CEO, Sherpa Innoventures invests

Beta-O2 said Monday that it has named Dr. Yuval Avni as its new CEO. Dr. Avni is a former partner at Giza VC. Beta-O2 also said that Sherpa Innoventures has invested in the company. Beta-O2, of Rosh Ha’ayin, Israel, is a biomedical company.

30 March 2015•3 mins read
Feature image
LinkedInXEmail
LinkedInXEmail